Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study).

Hitoshi IshiiNozomu KameiDai ShimonoTetsuji NiiyaTakahiro TosakiToru KitazawaDaisuke SuzukiYutaka WakasaHiroaki SeinoMariko OishiHiroshi OhashiKenshi HigamiHiroaki Akainull null

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)

jRCTs031200437.

Keyphrases

randomized controlled trial
study protocol
physical activity
systematic review
clinical trial
risk factors
combination therapy
smoking cessation